Pagina 1 a partire dal 48 risultati
BACKGROUND
This invention relates generally to compositions and methods for the treatment and nutritional support of patients. More specifically, this invention relates to the nutritional support of obese patients prior to, during and after hospitalisation for surgery, treatment of diseases or other
RELATED APPLICATION
This application is a non-provisional patent application of provisional patent application Ser. No. 61/473,779 filed Apr. 10, 2011.
FIELD AND BACKGROUND OF THE INVENTION
The present invention, in some embodiments thereof, relates to obesity treatment and, more particularly, but
BACKGROUND
1. Field of the Invention
The present invention relates to the field of treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases and obesity. More particularly, the present invention relates to a probiotic composition, and a method for treatment of obesity using the
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates to diets for humans. More particularly, the present invention relates to a dietary system for the treatment of obesity and for the lowering of saturated fats in the blood. The system includes a diet that restricts
TECHNICAL FIELD OF THE INVENTION
The present invention relates to an edible foam product with high in-mouth and gastric stability and to its use in the treatment or prevention of obesity.
The invention also concerns a pressurised container holding an edible liquid composition and a propellant, which
FIELD OF THE INVENTION
This invention relates to carbohydrate absorption inhibitor and method for manufacturing the same effective against e.g. diabetes prevention, diet, and so forth.
BACKGROUND OF THE INVENTION
Polysaccharide (starch, glycogen or the like) contained in food is hydrolyzed by
FIELD OF THE INVENTION
The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption.
BACKGROUND OF THE INVENTION
Glucose is an important source of energy to the cells in the human body and abundantly present in food ingredients. After
SUMMARY
In order to reduce the glycemic load in the daily nutrition of diabetics, obese and weight-reducing diets, this invention claims cooking or baking processes and procedures for conventional food, rich in carbohydrates, in which, the structure of the original complex carbohydrates (amyloses,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the field of weight reduction and maintenance of body weight. More specifically, the present invention provides a composition that is particularly suited for the long term management of weight in general, and
RELATED APPLICATIONS
None.
BACKGROUND OF THE INVENTION
Numerous studies have documented that medications which increase brain 5-HT, such as fenfluramine, are effective anorectic agents which help obese patients lose weight and which also decrease craving for sweets and carbohydrates (6,23). Evidence
SUMMARY
In order to reduce the glycemic load in the daily nutrition of diabetics, obese and for Metabolic Syndrome diets, this invention claims successive and interdependent: grain selection, milling, kneading, leavening, baking and storing processes and procedures for producing and preserving raw
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to novel use of the compounds of formula (1) in treating mammalian subjects, including humans, suffering from diseases or conditions which are characterized by reduced blood flow, oxygen availability or carbohydrate
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to novel use of the compounds of formula (I) in treating mammalian subjects, including humans, suffering from diseases or conditions which are characterized by reduced blood flow, oxygen availability or carbohydrate
BACKGROUND OF THE INVENTION
Miglitol (Glyset) is an oral alpha glucosidase inhibitor. Miglitol acts by a reversible inhibitor of membrane-bound intestinal .alpha.-glucoside hydrolase enzymes. Membrane intestinal .alpha.-glucosidases hydrolyze oligosaccharides and disaccharides to glucose and other
This invention relates to methods and formulations for the treatment of obesity.
BACKGROUND OF THE INVENTION
When it is required to bring about weight reduction in over-weight patients, it is naturally necessary to reduce their food intake, since the object of the weight-reduction treatment is to